Simon, Gregory E.; Fishman, Paul - In: PharmacoEconomics 13 (1998) 1 Part 1, pp. 61-70
While fluoxetine is considerably more expensive than tricyclic antidepressants (TCAs), some previous studies have suggested that general medical expenditures are lower among patients treated with fluoxetine. In this study, computerised pharmacy and cost-accounting records of a large health plan...